You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BACITRACIN ZINC AND POLYMYXIN B SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Bacitracin Zinc And Polymyxin B Sulfate, and what generic alternatives are available?

Bacitracin Zinc And Polymyxin B Sulfate is a drug marketed by Bausch And Lomb, Padagis Us, and Sciegen Pharms Inc. and is included in three NDAs.

The generic ingredient in BACITRACIN ZINC AND POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bacitracin Zinc And Polymyxin B Sulfate

A generic version of BACITRACIN ZINC AND POLYMYXIN B SULFATE was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB on January 26th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
  • What are the global sales for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
  • What is Average Wholesale Price for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
Summary for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Drug patent expirations by year for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Recent Clinical Trials for BACITRACIN ZINC AND POLYMYXIN B SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)N/A
Glaxo WellcomeN/A

See all BACITRACIN ZINC AND POLYMYXIN B SULFATE clinical trials

Pharmacology for BACITRACIN ZINC AND POLYMYXIN B SULFATE

US Patents and Regulatory Information for BACITRACIN ZINC AND POLYMYXIN B SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 064046-001 Jan 26, 1995 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 065022-001 Feb 27, 2002 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 064028-001 Jan 30, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.